QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
35.21 ^USD	+1.06%		-3.40%	-52.23%

05/06	QuidelOrtho Seeks Inorganic Options	CI
05/06	Transcript : QuidelOrtho Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 01:20 PM

Quidel Announces Revenue Guidance for the Fourth Quarter of 2018

January 08, 2019 at 02:40 am IST

Quidel Corporation announced that it expects revenues in the fourth quarter of 2018 to be in the range of $132 million to $133 million.

Latest news about QuidelOrtho Corporation

QuidelOrtho Seeks Inorganic Options	05/06	CI
Transcript : QuidelOrtho Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 01:20 PM	05/06
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ	16/05	CI
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	15/05	RE
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	15/05	MT
Jana Partners Acquires Stake in QuidelOrtho	14/05	MT
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say	14/05	RE
RBC Cuts Price Target on QuidelOrtho to $68 From $81, Keeps Outperform Rating	09/05	MT
Transcript : QuidelOrtho Corporation, Q1 2024 Earnings Call, May 08, 2024	09/05
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q1 Revenue $711M, vs. Street Est of $695.1M	09/05	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q1 EPS $0.44, vs. Street Est of $0.40	09/05	MT
QuidelOrtho Corporation Suspends Earnings Guidance for the Year 2024	09/05	CI
QuidelOrtho Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
QuidelOrtho Corporation Announces CEO Changes	02/05	CI
QuidelOrtho Corporation Appoints Brian J. Blaser as President and to the Board	02/05	CI
QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	02/04	MT
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	02/04	MT
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	02/04	CI
QuidelOrtho Receives Canada's Approval for Triage PLGF Test to Detect Pregnancy Complications	07/03	MT
Transcript : QuidelOrtho Corporation Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 04:00 PM	06/03
Sector Update: Health Care Stocks Mixed Late Afternoon	05/03	MT
Sector Update: Health Care	05/03	MT
QuidelOrtho Shares Decline Following UBS Downgrade	05/03	MT
UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	04/03	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon	22/02	MT

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Sector

Advanced Medical Equipment & Technology

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for QuidelOrtho Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

35.21 USD

Average target price

51.4 USD

Spread / Average Target

+45.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-52.23%	2.36B
SARTORIUS AG	-34.21%	14.68B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.01%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-10.06%	1.5B
BIOTAGE AB	+21.24%	1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-23.46%	880M
REVENIO GROUP OYJ	+1.33%	782M
CONTEC MEDICAL SYSTEMS CO.,LTD	-34.13%	752M
CELLAVISION AB	+23.58%	593M
VAREX IMAGING CORPORATION	-29.66%	589M

Medical Diagnostic & Testing Equipment

QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Quidel Announces Revenue Guidance for the Fourth Quarter of 2018

Latest news about QuidelOrtho Corporation

Chart QuidelOrtho Corporation

Company Profile

Income Statement Evolution

Ratings for QuidelOrtho Corporation

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment